PubRank

Kenneth Jamerson

Author PubWeight™ 55.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002 12.29
2 Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2013 8.91
3 The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol 2003 7.79
4 Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet 2012 6.69
5 Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 2010 3.16
6 Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol 2010 2.43
7 The rationale and design of the AASK cohort study. J Am Soc Nephrol 2003 2.34
8 Avosentan for overt diabetic nephropathy. J Am Soc Nephrol 2010 2.32
9 Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006 1.98
10 Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press 2007 1.52
11 Systolic blood pressure and cardiovascular outcomes during treatment of hypertension. Am J Med 2013 1.17
12 Cross-sectional study of health-related quality of life in African Americans with chronic renal insufficiency: the African American Study of Kidney Disease and Hypertension Trial. Am J Kidney Dis 2002 1.15
13 Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial. J Hypertens 2006 0.96
14 Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure. J Card Fail 2011 0.94
15 Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. Am J Cardiol 2011 0.91
16 Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease. Am J Cardiol 2013 0.87
17 A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension 2012 0.86
18 Effect of intensive blood pressure control on cardiovascular remodeling in hypertensive patients with nephrosclerosis. Int J Nephrol 2013 0.76
19 Obesity, blood pressure, and cardiovascular outcomes - Authors' reply. Lancet 2013 0.75
20 Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial. Blood Press 2008 0.75
21 The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension. Curr Hypertens Rep 2014 0.75
22 Therapeutic lifestyle changes for hypertension and cardiovascular risk reduction. J Clin Hypertens (Greenwich) 2003 0.75
23 Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association. J Am Heart Assoc 2017 0.75